explore -WSS

explore

author：explore 2025-09-28 18:47:32 - browse：1

Pfizer is this year’s anti-Eli Lilly. If David Ricks is the best biopharma CEO of 2023, then Pfizer CEO Albert Bourlais, unfortunately, the worst.

My annual Worst Biopharma CEO list is typically populated with blockheads and scoundrels. That’s not why Bourla is here. The reason is accountability. Strategic missteps, financial miscalculations, and scientific setbacks have plunged Pfizer into a deep crisis. Bourla is the man at the top, so the responsibility lies with him.

Pfizer shares have fallen 50% this year to their lowest level in more than a decade, erasing nearly $140 billion in market value. In 2022, the company delivered $100 billion in revenue, boosted by a widely used Covid vaccine and Covid treatment. This year, Covid product sales evaporated — and will fall further next year — leaving a vacuum Pfizer is struggling to fill with aging medicines nearing the end of their patent lives, and newer drugs and vaccines that have not performed as expected.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Precocious puberty in girls comes with mental health risks

WSS

The debate over Covid

Grail's uphill battle for Medicare to cover its cancer screening test

How to bring more disabled researchers into academia

Grail's uphill battle for Medicare to cover its cancer screening test

Britney Spears to release memoir, 'The Woman In Me,' later this year

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

knowledge

explore

hotspot

Guidelines to prevent youth baseball injuries need more muscle

Sen. Paul opposes bill to ban Chinese biotechs

FDA approval of Sarepta Duchenne genetic therapy gives me hope

IVF, abortion rights issues kick off Biden’s State of the Union

Supreme Court strikes down use of affirmative action

Blinken talks high

DIEP, the 'gold standard' of breast reconstruction, is under threat

RSV shot was 90% effective at preventing hospitalizations in kids

In age of alternative facts, a scholarly course on calling out crap

After half a century, Israel moves to evict squatter from his cave home on the beach

hotspot

Novo Nordisk obesity pill bests Wegovy in early trial

Amylyx ALS drug failure raises questions and concerns

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

Superbugs, antibiotic resistance get scrutiny in congress

hotspot

knowledge

explore

knowledge